ADT1006-Abelacimab Biosimilar (F11)-Research Biosimilar Antibody

F11 (coagulation factor XI) is a protein-coding gene that encodes coagulation factor XI in the coagulation cascade. Diseases associated with F11 include factor Xi deficiency and thrombocytopenia. This protein exists in plasma in the form of a proenzyme (a homodimer composed of two identical polypeptide chains connected by disulfide bonds) and is a unique plasma coagulation enzyme. Alpha Lifetech provides high-quality biosimilar solutions that maintain efficacy and safety while offering cost-effective alternatives for therapeutic use.
Request a Quote

PRODUCTS DETAILS

Abelacimab is under investigation in clinical trial NCT04755283 (Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation).

Contact us

Please feel free to give your inquiry in the form below We will reply you in 24 hours

Leave YourMessage

Thank you! We will reply you via email within 24 hours.

Return